ArticleFrontiers in oncology2026
A CT-based multi-scale fusion model with SHAP interpretation for preoperative differentiation between lung adenocarcinoma in situ/minimally invasive adenocarcinoma and invasive adenocarcinoma: a multicenter study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop a multi-scale model integrating radiomics, habitat, deep learning, and clinical information for preoperative precise differentiation between lung adenocarcinoma in situ/minimally invasive adenocarcinoma and invasive adenocarcinoma in ground-glass nodules (GGNs). Methods: A total of 621 patients with GGNs from two centers were retrospectively enrolled. Radiomics, habitat, deep learning (2D, 2.5D, and 3D), and clinic models were constructed separately. Early fusion (feature-level fusion) and late fusion (decision-level fusion) strategies were systematically compared. The SHapley Additive exPlanations method was applied for interpretability analysis of the optimal model. Results: The early fusion model demonstrated superior performance, achieving areas under the receiver operating characteristic curves of 0.988, 0.903, and 0.872 in the training, internal validation, and external testing cohorts, respectively. Among the deep learning architectures, the 2.5D ResNet50 achieved the best performance. Conclusions: This multi-scale early fusion model provides robust support for preoperative precise diagnosis and individualized treatment decision-making for GGNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.